The SUSTAIN 6 cardiovascular outcomes trial, which followed patients for a median of 2.1 years, demonstrated a 26% reduction in the primary composite endpoint of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke compared to placebo
Find out in our new answer to the question: Do electrolyte supplements, like Pedialyte, help with hangovers
The Decision Framework A simple framework for the GLOW vs KLOW decision: Choose GLOW if: Your research focuses on the three GLOW pathways without specific anti-inflammatory consideration Cost optimization is a priority You're maintaining consistency with existing GLOW-based protocols The simpler three-peptide framework better matches your research question Choose KLOW if: Your research includes anti-inflammatory mechanism considerations Comprehensive four-pathway mechanism coverage is the priority You're studying skin or tissue research with inflammatory components You're building research on the most current combination peptide logic Inflammatory tissue research is part of the research question Either choice maintains: Same manufacturing approach (SPPS) Same quality framework (Janoshik third-party testing, 99% HPLC purity) Same storage and reconstitution requirements Same Canadian-domestic supply Same research-use-only framework Frequently Asked Questions What's the difference between KLOW and GLOW
In 2024 the FDA issued a warning about a spike in overdoses and adverse side effects that was largely attributed to dosing errors with these drugs
While it is true that certain foods contain small amounts of glutathione, it is the use of a high quality liposomal glutathione supplement that has been proven through scientific research to be the best way to boost glutathione levels in the body.
